Literature DB >> 12042382

Serotonin syndrome in a renal transplant patient.

E H Wong1, N N Chan, K H Sze, K H Or.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2002        PMID： 12042382      PMCID： PMC1279917          DOI： 10.1258/jrsm.95.6.304

Source DB:  PubMed          Journal:  J R Soc Med        ISSN： 0141-0768            Impact factor:   5.344


× No keyword cloud information.
  4 in total

Review 1.  The serotonin syndrome.

Authors:  H Sternbach
Journal:  Am J Psychiatry       Date:  1991-06       Impact factor: 18.112

2.  Serotonin syndrome resulting from drug interactions.

Authors:  B S Chan; A Graudins; I M Whyte; A H Dawson; G Braitberg; G G Duggin
Journal:  Med J Aust       Date:  1998-11-16       Impact factor: 7.738

3.  Adverse consequences of fluoxetine-MAOI combination therapy.

Authors:  J P Feighner; W F Boyer; D L Tyler; R J Neborsky
Journal:  J Clin Psychiatry       Date:  1990-06       Impact factor: 4.384

4.  Enhancement of serotonergic neural activity contributes to cyclosporine-induced tremors in mice.

Authors:  H Shuto; Y Kataoka; A Kanaya; K Matsunaga; M Sueyasu; R Oishi
Journal:  Eur J Pharmacol       Date:  1998-01-02       Impact factor: 4.432
  4 in total
  3 in total

1.  Behavioral adaptation in C. elegans produced by antipsychotic drugs requires serotonin and is associated with calcium signaling and calcineurin inhibition.

Authors:  Dallas R Donohoe; Raymond A Jarvis; Kathrine Weeks; Eric J Aamodt; Donard S Dwyer
Journal:  Neurosci Res       Date:  2009-04-05       Impact factor: 3.304

2.  Serotonin syndrome after single doses of co-amoxiclav during treatment with venlafaxine.

Authors:  Henry Connor
Journal:  J R Soc Med       Date:  2003-05       Impact factor: 18.000

3.  Hospitalized poisonings after renal transplantation in the United States.

Authors:  Kevin C Abbott; Rebecca A Viola; Lawrence Y Agodoa
Journal:  BMC Nephrol       Date:  2002-11-26       Impact factor: 2.388
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.